MedTrace Logo

Variable Effects of Anti-diabetics on Stress Hyperglycemia Ratio

NCT05822674 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2023-04-21

No results posted yet for this study

Summary

A blood glucose level of equal to or greater than 180 mg/dL that occurred during stress in a patient without diabetes mellitus (DM) is termed stress hyperglycemia (SH). The stress hyperglycemia ratio (SHR) is defined as the fasting blood glucose divided by the blood glucose level that is calculated from the glycosylated hemoglobin (HBA1c) value on admission. A significantly higher SHR is associated with worse prognostic biomarkers in diabetic patients with complications

Conditions

Interventions

DRUG

Sitagliptin/metformin ( 50/500mg) Oral Tablet

The drug was prescribed once daily per oral for 10 weeks

DRUG

Empagliflozin/metformin(10/500mg) Oral Tablet

The drug was prescribed once daily per oral for 10 weeks

Sponsors & Collaborators

  • University of Diyala

    lead OTHER

Principal Investigators

  • Ismail Latif · The Dean College of Medicine, University of Diyal

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-12-31
Completion
2023-02-01

Countries

  • Iraq

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05822674 on ClinicalTrials.gov